You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 6, 2025

Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow
Published on: May 26, 2023
Henry David Jeffry Hogg1,2,3, Katie Brittain4, James Talks5
1Research, Development and Innovation, University Hospitals Birmingham NHS Foundation Trust, Level 2 ITM, Queen Elizabeth HospitalMindelsohn Way, Birmingham, B15 2GW, UK. J.Hogg.1@bham.ac.uk.
Artificial intelligence (AI) can optimize neovascular age-related macular degeneration (nAMD) treatment scheduling. This study guides early adopters on implementing AI to improve macular services and patient outcomes.
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
07:12Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
Published on: April 11, 2025
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: